We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Beneficial effect of LDL-apheresis in refractory nephrotic syndrome.
- Authors
Muso, Eri
- Abstract
LDL-apheresis is a method to correct dyslipidemia rapidly. It is expected to alleviate the tissue toxicity of persistent dyslipidemia in not only primary, but also in secondary dyslipidemia associated with refractory nephrotic syndrome, and to have a protective effect against glomerular and tubular injury as expected in atherosclerosis. In addition, the effectiveness of LDL-apheresis to promote the remission of nephrotic syndrome has been recognized. In Japan, LDL-A to control hyperlipidemia in patients with refractory nephrotic syndrome associated with focal segmental glomerulosclerosis is covered by national health insurance. Here, the hypothetical mechanism behind its effect and the evidence for its effectiveness over a long period are reviewed.
- Subjects
JAPAN; LOW density lipoproteins; NEPHROTIC syndrome; HEMAPHERESIS; DYSLIPIDEMIA; ATHEROSCLEROSIS; HYPERLIPIDEMIA; NATIONAL health insurance
- Publication
Clinical & Experimental Nephrology, 2014, Vol 18, Issue 2, p286
- ISSN
1342-1751
- Publication type
Academic Journal
- DOI
10.1007/s10157-013-0930-5